To further investigate whether dynamic changes in CD4+ T cell density within the TME provide early insights into immunotherapy efficacy, we subjected additional PyMT tumor-bearing ICI-treated hCD4-KI mice to in vivo 64Cu-CD4-Nb1-PET imaging. The gene discussed is CD4; the disease is neoplasm.